Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104219 · ClinicalTrials.gov registry record
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- 32
- Enrollment target
NCT02104219 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 32 participants.
The verdict
NCT02104219 has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104219
The ClinicalTrials.gov registry entry for NCT02104219 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02104219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104219 about?
NCT02104219 is a clinical study titled "Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)". The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP.
What is the current status of trial NCT02104219?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2014-03. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT02104219?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.